intratumoral STING agonist - Merck, Kenilworth, NJ

intratumoral STING agonist

in Ph. II for met. HNSCC

cyclic dinucleotide derivative

J. Med. Chem.

Merck, Kenilworth, NJ

Context. MK-1454 (Merck) is an intratumoral stimulator of interferon (IFN) genes (STING) agonist that is being developed for treatment of advanced solid tumors and lymphomas. The molecule follows Aduro’s…

 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.